Deal payment carves into Biogen Idec's profit
July 16, 2009 at 11:41 AM EDT
Biogen Idec reports lower second-quarter earnings, due in part to a payment to Acorda Therapeutics under a newly signed partnering deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.